Guidelines for the clinical evaluation of radiopharmaceutical drugs
By: Group Leader for Radiopharmaceutical Drugs, Division of Oncology and Radiopharmaceutical Drug Products, Bureau of Drugs, Food and Drug Administration
Edition: Rev. Oct. 1981
Series: HHS (FDA) -- 81-3120; DHHS publication -- no. (FDA) 81-3120
Publisher: The Division; For sale by the Supt. of Docs., U.S. G.P.O.
Published: 1981
Place of publication: Rockville, Md; Washington, D.C
Language: eng
Number of pages: 14
Subjects: Radiopharmaceuticals -- Testing